List view / Grid view
19 May 2014 | By AbbVie
AbbVie has named Michael Severino, M.D. its new Executive Vice President, Research and Development and Chief Scientific Officer...
19 May 2014 | By Boehringer Ingelheim
Results from the Phase III INPULSIS™ trials, published online in the New England Journal of Medicine, show nintedanib* significantly slowed disease progression in patients with idiopathic pulmonary fibrosis...
16 May 2014 | By Pfizer
Public health initiative aims to increase unacceptably low adult vaccination rates...
16 May 2014 | By Novo Nordisk
Results from the SCALE™ Obesity and Pre-diabetes phase 3a trial will be presented on 16 May, 2014 for the first time at the 23rd Annual Congress of the American Association of Clinical Endocrinologists...
16 May 2014 | By Novartis
Novartis announced that the US Food and Drug Administration has issued a Complete Response Letter regarding the Biologics License Application for RLX030...
16 May 2014 | By Abbott
Abbott enhances its position in fast-growing Latin American market, more than doubling its branded generics pharmaceutical sales and presence in the region...
15 May 2014 | By Enigma Diagnostics
Enigma Diagnostics Ltd announced a collaboration agreement with China’s National Institute for Communicable Disease Control and Prevention, China Center for Disease Control and Prevention...
15 May 2014 | By Novartis
Novartis Pharmaceuticals Corporation has settled its litigation with the United States subsidiary of Sun Pharmaceutical Industries Ltd. relating to Novartis patents covering the use of certain polymorphic forms of Gleevec®...
15 May 2014 | By AstraZeneca
New data from AstraZeneca’s investigational cancer medicines demonstrate the rapid progression of its oncology pipeline...
15 May 2014 | By Boehringer Ingelheim
Boehringer Ingelheim announced new overall survival results from a post-hoc analysis combining the data of two Phase III trials (LUX-Lung 3 and LUX-Lung 6)...
14 May 2014 | By Roche
Roche announced that new data on nine approved and 18 investigational medicines will be presented during the 50th American Society of Clinical Oncology Annual Meeting...
14 May 2014 | By The European Medicines Agency
The European Commission and the US Department of Health and Human Services have published a progress report of the Transatlantic Taskforce on Antimicrobial Resistance...
14 May 2014 | By Johnson & Johnson
Janssen Pharmaceuticals, Inc., announced the submission of supplemental New Drug Applications for once-monthly atypical long-acting antipsychotic INVEGA® SUSTENNA® (paliperidone palmitate) to the U.S. Food and Drug Administration...
14 May 2014 | By AstraZeneca
AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into a clinical study collaboration with biopharmaceutical company Incyte Corporation...
13 May 2014 | By Merck
Merck announced that it signed an agreement for Santen Pharmaceutical Co., Ltd. (Santen) to purchase Merck’s ophthalmology products...
